Gilead to Pay $510 Million for YM BioSciences to Expand Cancer Portfolio
Gilead to Pay 0 Million for YM BioSciences to Expand Cancer Portfolio
Filed under: drug treatment news 2011
The treatment, known as CYT387, is the same class of drug as Jakafi, a treatment marketed by Incyte Pharmaceuticals (INCY) and Novartis AG (NOVN). Jakafi was the first drug approved by the FDA in 2011 to specifically treat myelofibrosis. The drug is on …
Read more on NASDAQ
STOP HIV/AIDS funding not enough for gay men: critics
Filed under: drug treatment news 2011
Gay health advocates say the BC Liberals' promise to spend nearly $ 20 million annually to expand a pilot program aimed at reducing HIV transmission through early testing and treatment is overly focused on just one piece of the prevention puzzle. “The …
Read more on Xtra.ca
Researchers say Alzheimer's studies must focus on abnormalities in patients …
Filed under: drug treatment news 2011
Studies nationwide generally deal with possible causes and risk factors of Alzheimer's, as well as trials of drugs and behavior modifications aimed at treatment, prevention and improving diagnosis. More than a …. Writing in the December 2011 issue of …
Read more on Las Vegas Review – Journal
Shattered: Her boy's diagnosis turned Nadiyah Gonzales's world 'upside down'
Filed under: drug treatment news 2011
But in 2011, Kalel appeared anything but a boy of steel. He was plagued by a persistent cough and fevers. Doctors, believing he had an infection, prescribed antibiotics. … Souter has connected Gonzales with the Housing Help Centre, and is trying to …
Read more on St. Catharines Standard